Washington: Ovulation-stimulating fertility drugs temporarily elevate estrogen levels, which is known to play an important role in breast cancer, a new study has found.While some studies report increased breast cancer risk following infertility treatment, other analyses have been inconclusive.In order to determine the risk of young-onset breast cancer after use of ovulation-stimulating fertility drugs, Chunyuan Fei, Ph.D., at the National Institute of Environmental Health Sciences (NIEHS), and colleagues, conducted a sister-matched case-control study, in part funded by Susan Komen for the Cure, called the Two Sister Study (which was developed from the Sister Study), which looked at women diagnosed with breast cancer under the age of 50 years and their breast cancer-free control sisters, who were studied between September 2008-December 2010.They looked specifically at fertility-drug exposure according to whether or not it had resulted in a pregnancy lasting at least 10 weeks.
Indian jawan`s beheading: Army Chief warns Pak
Exclusive interview with Natwar Singh
Aamir Khan poses naked in `PK` poster
Trilokpuri mishap: E-rickshaw driver arrested